Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Non-cash Items (2019 - 2025)

Historic Non-cash Items for Outlook Therapeutics (OTLK) over the last 4 years, with Q4 2025 value amounting to $4.3 million.

  • Outlook Therapeutics' Non-cash Items fell 3363.44% to $4.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.3 million, marking a year-over-year decrease of 3363.44%. This contributed to the annual value of $2.0 million for FY2025, which is N/A changed from last year.
  • Latest data reveals that Outlook Therapeutics reported Non-cash Items of $4.3 million as of Q4 2025, which was down 3363.44% from $2.0 million recorded in Q3 2025.
  • Outlook Therapeutics' Non-cash Items' 5-year high stood at $6.5 million during Q4 2024, with a 5-year trough of $2.0 million in Q3 2025.